The Timing of Neonatal Brain Damage
- 1 September 2006
- journal article
- review article
- Published by S. Karger AG in Neonatology
- Vol. 90 (3) , 145-155
- https://doi.org/10.1159/000092517
Abstract
Although neonatal morbidity and mortality are less than in the past, the risk of pre-natal and neonatal brain damage has not been eliminated. In order to optimize pre-natal, perinatal and neonatal care, it is necessary to detect factors responsible for brain damage and obtain information about their timing. Knowledge of the timing of asphyxia, infections and circulatory abnormalities would enable obstetricians and neonatologists to improve prevention in pre-term and full-term neonates. Cardiotocography has been criticized as being too indirect a sign of fetal condition and as having various technical pitfalls, though its reliability seems to be improved by association with pulse oximetry, fetal blood pH and electrocardiography. Neuroimaging is particularly useful to determine the timing of hypoxic-ischemic brain damage. Cranial ultrasound has been used to determine the type and evolution of brain damage. Magnetic resonance has also been used to detect antenatal, perinatal and neonatal abnormalities and timing on the basis of standardized assessment of brain maturation. Advances in the interpretation of neonatal electroencephalograms have also made this technique useful for determining the timing of brain lesions. Nucleated red blood cell count in cord blood has been recognized as an important indication of the timing of pre-natal hypoxia, and even abnormal lymphocyte and thrombocyte counts may be used to establish pre-natal asphyxia. Cord blood pH and base excess are well-known markers of fetal hypoxia, but are best combined with heart rate and blood pressure. Other markers of fetal and neonatal hypoxia useful for determining the timing of brain damage are assays of lactate and markers of oxidative stress in cord blood and neonatal blood. Cytokines in blood and amniotic fluid may indicate chorioamnionitis or post-natal infections. The determination of activin and protein S100 has also been proposed. Obstetricians and neonatologists can therefore now rely on various methods for monitoring the risk of brain damage in the antenatal and post-natal periods.Keywords
This publication has 101 references indexed in Scilit:
- Fetal ECG waveform analysisBest Practice & Research Clinical Obstetrics & Gynaecology, 2004
- The CTG and the timing and mechanism of fetal neurological injuriesBest Practice & Research Clinical Obstetrics & Gynaecology, 2004
- Hypotension in the very low birthweight infant: the old, the new, and the uncertainArchives of Disease in Childhood: Fetal & Neonatal, 2003
- The critical role of perinatal pathologyBJOG: An International Journal of Obstetrics and Gynaecology, 2003
- Interleukin 6 determinations in cervical fluid have diagnostic and prognostic value in preterm premature rupture of membranesAmerican Journal of Obstetrics and Gynecology, 2000
- Symptomatic Ischemic Stroke in Full-Term NeonatesStroke, 2000
- Nucleated red blood cells: A marker for fetal asphyxia?American Journal of Obstetrics and Gynecology, 1995
- Determining the time before birth when ischemia and hypoxemia initiated cerebral palsyObstetrics & Gynecology, 1995
- Predictive value of early continuous amplitude integrated EEG recordings on outcome after severe birth asphyxia in full term infants.Archives of Disease in Childhood: Fetal & Neonatal, 1995
- DEVELOPMENT OF CEREBRAL PALSY AFTER ULTRASONOGRAPHIC DETECTION OF PERIVENTRICULAR CYSTS IN THE NEWBORNDevelopmental Medicine and Child Neurology, 1985